Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Serotonin Syndrome 3Neuroendocrine Tumors 3Pancreatic Neoplasms 1Neoplasms 1Diarrhea 1Carcinoid Tumor 1Carcinoid Heart Disease 1Cachexia 1

Interventions

gallium Ga 68 dotatate 2veliparib 1telotristat ethyl 1Temozolomide 1Panitumumab 1Octreotide 1Capecitabine 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Carcinoid Tumor × telotristat ethyl × Clear all
NCT04672876 2021-12-17

Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine Tumors

University of Chicago

Phase 2 Withdrawn
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡